Literature DB >> 33322959

Pregnancy outcomes among symptomatic and asymptomatic women infected with COVID-19 in the west of Iran: a case-control study.

Ensiyeh Jenabi1, Saeid Bashirian2, Salman Khazaei3, Seyedeh Zahra Masoumi4, Samereh Ghelichkhani5, Firoozeh Goodarzi5, Mohammad Mirzaei6.   

Abstract

BACKGROUND: The purpose of this study was to investigate pregnancy outcomes among symptomatic and asymptomatic women infected with coronavirus disease 2019 (COVID-19) in the west of Iran.
MATERIALS AND METHODS: In this case-control study, 45 pregnant women infected with symptomatic COVID-19 were compared with 45 pregnant women infected with asymptomatic COVID-19. The cases included women were referred for delivery to hospitals of Hamadan Province and infected with COVID-19-related symptoms. The diagnosis of COVID-19 was based on the results of real-time reverse-transcriptase polymerase-chain-reaction (rRT-PCR) detection. The control group included asymptomatic women who were referred for delivery to hospitals in Hamadan Province infected with COVID-19. Data were collected by a checklist. For the data analysis, the Stata version 12 was used (StataCorp, College Station, TX).
RESULTS: The odds of cesarean delivery in symptomatic women was more the fourfold higher (OR = 4.12, 95% CI (1.7, 10.05), p = .002). Moreover, the odds of LBW was significantly higher in symptomatic women (OR = 2.1, 95% CI (1.2, 6.29), p = .035).
CONCLUSIONS: Our findings showed that cesarean delivery and LBW were significantly higher in symptomatic women compared with asymptomatic women. In areas with high COVID-19 pandemics, the performance of the PCR test is recommended for all pregnant women upon admission for delivery.

Entities:  

Keywords:  Coronavirus; pregnancy outcomes; symptomatic; asymptomatic; case-control

Mesh:

Year:  2020        PMID: 33322959     DOI: 10.1080/14767058.2020.1861599

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  6 in total

Review 1.  A Comprehensive Analysis of Maternal and Newborn Disease and Related Control for COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2021-03-17

2.  Differences in pregnancy and perinatal outcomes among symptomatic versus asymptomatic COVID-19-infected pregnant women: a systematic review and meta-analysis.

Authors:  Durray Shahwar A Khan; La-Raib Hamid; Anna Ali; Rehana A Salam; Nadeem Zuberi; Zohra S Lassi; Jai K Das
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-01       Impact factor: 3.007

3.  Comparison of Maternal, Perinatal, and Neonatal Outcomes of Asymptomatic and Symptomatic Pregnant Women with Coronavirus Disease-2019.

Authors:  Tayfun Vural; Burak Bayraktar; Suna Yildirim Karaca; Ozan Odabas; Nisel Yilmaz; Pınar Samlioglu; Mehmet Ozeren
Journal:  Medeni Med J       Date:  2022-03-18

Review 4.  Clinical Characteristics and Outcomes of COVID-19 During Pregnancy-a Retrospective Cohort Study.

Authors:  Sarah Dollinger; Rita Zlatkin; Chen Jacoby; Anat Shmueli; Shiri Barbash-Hazan; Rony Chen; Hadas Zafrir Danieli; Shay Sukenik; Eran Hadar; Arnon Wiznitzer
Journal:  Reprod Sci       Date:  2022-04-21       Impact factor: 2.924

5.  An outbreak of infection due to severe acute respiratory corona virus-2 in a neonatal unit from a low and middle income setting.

Authors:  Firdose Lambey Nakwa; Reenu Thomas; Alison van Kwawegen; Nandi Ntuli; Karabo Seake; Samantha Jane Kesting; Noela Holo Bertha Kamanga; Dikeledi Maureen Kgwadi; Neema Chami; Tshiamo Mogajane; Claude Ondongo-Ezhet; Thulisile Nelly Maphosa; Stephanie Jones; Vicky Lynne Baillie; Shabir Ahmed Madhi; Sithembiso Velaphi
Journal:  Front Pediatr       Date:  2022-07-28       Impact factor: 3.569

6.  Timing and severity of COVID-19 during pregnancy and risk of preterm birth in the International Registry of Coronavirus Exposure in Pregnancy.

Authors:  Louisa H Smith; Camille Y Dollinger; Tyler J VanderWeele; Diego F Wyszynski; Sonia Hernández-Díaz
Journal:  BMC Pregnancy Childbirth       Date:  2022-10-18       Impact factor: 3.105

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.